WallStreetZenWallStreetZen

NASDAQ: XBIO
Xenetic Biosciences Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Xenetic Biosciences revenue was $2.50M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $648.8k, up 5.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, XBIO annual revenue was $2.5M, with -1.6% growth year-over-year.

XBIO past revenue growth

How has XBIO's revenue growth performed historically?

Company
-1.56%
Industry
497.69%
Market
20.68%
XBIO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
XBIO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
XBIO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

XBIO revenue history

Current Revenue
$2.5M
Current Earnings
-$4.0M
Current Profit Margin
-158.4%

Be the first to know when XBIO announces revenue.

XBIO Revenue History By Year

XBIO Yearly RevenueXBIO RevenueXBIO ChangeXBIO Revenue Growth
2024-12-31$2.50M-$39.70k-1.56%
2023-12-31$2.54M$833.06k+48.80%
2022-12-31$1.71M$546.23k+47.06%
2021-12-31$1.16M$723.75k+165.64%
2020-12-31$436.94k$419.88k+2,460.31%
2019-12-31$17.07kN/AN/A
2018-12-31$0.00-$7.59M-100.00%
2017-12-31$7.59M$4.59M+152.83%
2016-12-31$3.00MN/AN/A
2015-12-31$0.00N/AN/A
2014-12-31$0.00-$1.00M-100.00%
2013-12-31$1.00M$706.40k+240.60%
2012-12-31$293.60kN/AN/A

1 of 1

Xenetic Biosciences Revenue FAQ

What was XBIO's revenue last quarter?

On Invalid Date, Xenetic Biosciences (NASDAQ: XBIO) reported Q4 2024 revenue of $648.82 thousand up 3.44% year over year. In the same quarter last year, Xenetic Biosciences's revenue was $671.96 thousand.

What was Xenetic Biosciences's revenue in 2024?

Xenetic Biosciences's annual revenue for the twelve months ending Dec 31, 2024 was $2.50 million, a 1.56% decrease year over year.

How much does Xenetic Biosciences make in a day?

Based on Xenetic Biosciences annual revenue for the past five years, XBIO makes an average of $4,572.51 per day.

What was Xenetic Biosciences's annual revenue growth in the past year?

As of Q2 2025, Xenetic Biosciences's revenue has grown -1.56% year over year. This is 499.26 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Xenetic Biosciences's revenue in the past year totaled $2.50 million.

How much does Xenetic Biosciences make in a year?

Xenetic Biosciences's revenue by year for the past five years is:
  • Xenetic Biosciences's revenue for the twelve months ending Dec 31, 2024 was $2.50 million, a 1.56% decrease year over year.
  • Xenetic Biosciences's annual revenue for Dec 31, 2023 was $2.54 million, a 48.8% increase from 2022.
  • Xenetic Biosciences's annual revenue for 2022 was $1.71 million, a 47.06% increase from 2021.
  • Xenetic Biosciences's annual revenue for 2021 was $1.16 million, a 165.64% increase from 2020.
  • Xenetic Biosciences's annual revenue for 2020 was $436.94 thousand, a 2,460.31% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.